Colonrectal Cancer (CRC)
1 clinical trials · Condition
◉ Watch Colonrectal Cancer (CRC)
| Record | Firm | Date |
|---|---|---|
| Nelmastobart in Combination With Tas-102 and Bevacizumab in Recurrent/Metastatic Colorectal Cancer (NCT07656038) | STCube, Inc. | 2026-06-30 |
Track Colonrectal Cancer (CRC) automatically
Every clearance here is in the API, with alerts when new ones post.